Menstrual Cramps Treatment Market by Type, Treatment, Distribution Channel, and Geography: Forecast up to 2027

Menstrual cramps are pains which cause in lower abdomen and in the back. This is also known as dysmenorrhea. The pain can remain for 2 to 3 days. Chemicals known as prostaglandins are produced by the body which is responsible for most of the symptoms connected with menstrual discomfort. People with more amounts of prostaglandin may experience highly severe uterine contractions and pain. Dysmenorrhea is categorized on the basis of type which includes primary dysmenorrhea and secondary dysmenorrhea. Surge in demand for menstrual cramps treatment because of the increase in cases of menstrual cramps propel the menstrual cramps treatment market growth. Apart from this, the rise in government support for healthcare infrastructure developments further fuel the growth of the market. Apart from this, the minimum price of over-the-counter medicines such as ibuprofen leads to growth in demand for menstrual cramps drugs and further accelerates the menstrual cramps treatment market growth. However, the less demand for menstrual cramps treatment in under development nations may impede the market growth. The Menstrual Cramps Treatment Market is projected to grow at a rate of 4.0% CAGR by 2027.

Menstrual Cramps Treatment Market by Type

• Primary Dysmenorrhea
• Secondary Dysmenorrhea

Menstrual Cramps Treatment Market by Treatment

• Non-steroidal Anti-inflammatory Drugs
• Hormonal Therapy

Menstrual Cramps Treatment Market by Distribution Channel

• Hospital Pharmacies
• Drug stores and Retail Pharmacies
• Online Providers

Menstrual Cramps Treatment Market by Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

The types are bifurcate into Primary Dysmenorrhea and Secondary Dysmenorrhea. The Primary Dysmenorrhea segment is obtaining significant popularity in the Market by capturing a highest share in the menstrual cramps treatment market. The reason which propels the segment growth is the surge in occurrence of high menstrual bleeding among women and changes in lifestyle, which results in primary dysmenorrhea.

Further on the basis of treatment, the market segmented into Non-steroidal Anti-inflammatory Drugs and Hormonal Therapy. The Non-steroidal Anti-inflammatory Drugs segment held the largest share in the menstrual cramps treatment market. The largest share of the segment is attributed to the benefits of Non-steroidal Anti-inflammatory Drugs. The benefits include low cost, high availability in pharmacy and drug stores, and high therapeutic effect due to which most of the women use Non-steroidal Anti-inflammatory Drugs.

Further, in the market for Distribution Channel is divided into Hospital Pharmacies, Drug stores and Retail Pharmacies ad Online Providers. Among which the drugs stores and retail pharmacies segment held a significant share in the menstrual cramps treatment market. This is can be accredited to the huge sales of medicines from drug stores and retail pharmacies and a surge in patients looking treatment for menstrual cramps.

Geographically, the menstrual cramps treatment market is classified into North America, Europe, Asia Pacific and rest of the world. Among them the North America region has captured the maximum share in the market. Owing to the existence of leading vendors in the region, increase in government initiatives as well as well developed healthcare infrastructure in the region the market is growing highly in the region.

Furthermore, the changing lifestyle of people around the world is projected to influence the global market dynamic during the forecast period. Changing lifestyles along with the unhealthy food habits have significant impact on the human body. This further leads to increasing prevalence of dysmenorrhea/ menstrual cramps among women. In addition, the environmental changes are also considered a contributing factor which increases the risk of menstrual cramps.

AbbVie Inc., Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Johnson and Johnson, Bayer AG, Taj Pharmaceuticals Limited, Abbott Laboratories, Pfizer Inc., and GlaxoSmithKline plc, are some of the competitors that are dominating the menstrual cramps treatment market.

Therefore, the women around the world have become more conscious about the menstrual cramps than past now-a-days and the problems regarding the dysmenorrhea are increasing as well. Since, women are seeking for pain relief where menstrual cramps treatments are highly available in the market.

Key reasons to purchase the report:

• To examine and analyze the menstrual cramps treatment market size by key regions, type treatment and distribution channel.
• To understand the structure of menstrual cramps treatment Market by recognizing its various sub segments.
• Emphasizes on the key global menstrual cramps treatment competitors, to define, describe and analyze the market competition landscape, market share, value, SWOT analysis and development plans in next few years.
• To analyze the menstrual cramps treatment market in terms of individual growth trends, future prospects and their contribution to the whole market.